Additional Patent Term Adjustment (PTA) may be available for some cases where an Information Disclosure Statement (IDS) was filed after a reply. Recently in Supernus Pharmaceuticals, Inc. v. Iancu, the U.S. Court of Appeals for the Federal Circuit held that the USPTO had incorrectly reduced the PTA based on applicant delay for a period of time during which there was no action that the applicant could take to conclude prosecution of the patent.
Patent Term Adjustments (PTAs) alter the patent term and are meant to account for delays in patent prosecution, and usually increase the life of the patent beyond their normal 20 year term. They are usually calculated by accounting for prosecution delays by both the applicant and the USPTO. The PTO automatically grants adjustments, but patentees can petition to recalculate the adjustment if they disagree with the PTO's calculation.
Max-Insight is a suite of tools that is offered by MaxVal for patent professionals. The tools are designed to help with routine tasks that can consume a lot of a patent professional’s time.